Table 2 Survival analysis for OS and CSS of UHFLM, UTCLM and USFLM patients
| Â | Â | OS | CSS | ||||
|---|---|---|---|---|---|---|---|
1 year(%) | 3 years(%) | 5 years(%) | 1 year(%) | 3 years(%) | 5 years(%) | ||
UHFLM | Total | 42.8 | 11.0 | 5.5 | 42.8 | 12.0 | 6.0 |
Non-PTR | 31.6 | 2.1 | 2.1 | 31.8 | 2.8 | 2.8 | |
PTR | 57.8 | 21.2 | 9.1 | 57.7 | 22.6 | 9.7 | |
UTCLM | Total | 50.6 | 15.1 | 6.9 | 51.2 | 16.3 | 7.8 |
Non-PTR | 37.5 | 5.8 | 1.1 | 37.8 | 6.5 | 1.2 | |
PTR | 59.7 | 21.2 | 10.7 | 60.5 | 22.7 | 12.0 | |
USFLM | Total | 60.8 | 22.1 | 14.2 | 61.7 | 23.0 | 14.9 |
Non-PTR | 41.2 | 13.0 | 4.1 | 43.2 | 13.7 | 4.3 | |
PTR | 72.9 | 27.7 | 19.8 | 72.9 | 28.8 | 20.6 | |